glivec

Despite alleged pressure from the US protecting pharmaceutical interests, international experts are vehemently defending Colombia’s right to produce a cheaper version of a life-saving drug for cancer. Some 122 lawyers, academics, and…

Read more Experts defend Colombia in battle with Novartis over cheaper cancer drug

Leave your vote

0 points
Upvote Downvote

From Colombia Reports. Click here to go there.